LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 17.25 | 11834 | 6239 | 1.8967 | 1.1565 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 17.25 | 12742 | 6239 | 2.0422 | 1.1753 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.06 | 17.25 | 204 | 143 | 1.4244 | 1.2457 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.06 | 17.25 | 305 | 143 | 2.1297 | 1.5619 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.03 | 17.25 | 644 | 273 | 2.3559 | 1.4797 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.03 | 17.25 | 552 | 273 | 2.0193 | 1.3856 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.01 | 17.25 | 732 | 389 | 1.8793 | 1.3012 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.01 | 17.25 | 897 | 389 | 2.3030 | 1.4077 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.98 | 17.25 | 797 | 445 | 1.7907 | 1.2646 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 8.98 | 17.25 | 992 | 445 | 2.2289 | 1.3728 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.95 | 17.25 | 2 | 471 | 0.0042 | -0.3633 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.95 | 17.25 | 835 | 471 | 1.7707 | 1.2544 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.95 | 17.25 | 1054 | 471 | 2.2351 | 1.3671 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.91 | 17.25 | 5 | 494 | 0.0101 | -0.2257 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.91 | 17.25 | 908 | 494 | 1.8349 | 1.2671 | MN20160310_N02 | E06 |